ADVI
  • About Us
  • People
  • Insights
    • Publications
    • 2024 Presidential Election
    • Cell and Gene
    • Inflation Reduction Act
    • Case Studies
    • Events
    • News
    • Videos
  • Solutions
    • Policy, Research, and Analysis
    • Market Access
    • Reimbursement
    • Strategic Analytics, Value and Economics
      • ADVI Databoard
  • Join Us
  • Get in Touch
Get in Touch

Service: Economic Modeling

In The News Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States
In The News Cost Effectiveness of Metal Stents in Pancreatic Cancer
In The News Cost-effectiveness of the once-daily efavirenz/emtricitabine/tenofovir tablet compared with the once-daily elvitegravir/cobicistat/emtricitabine/tenofovir tablet as first-line antiretroviral therapy in HIV-infected adults in the US
In The News Cost-Effectiveness of Elvitegravir/Cobicistat/ Emtricitabine/Tenofovir Compared with Efavirenz/Emtricitabine/Tenofovir as First-Line HIV Antiretroviral Therapy in the US Adult Population
In The News Optimal Interval for Routine Cytologic Screening in the United States
In The News Health and Economic Impact of Human Papillomavirus 16 and 18 Vaccination of Preadolescent Girls and Cervical Cancer Screening of Adult Women in Peru
In The News Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern Africa
In The News The Cost-effectiveness of Improving Cancer Screening Compliance
In The News Cost-effectiveness of cervical cancer screening with primary human papillomavirus testing in Norway

Posts pagination

< Previous page 1 … 8 9 10 … 12 Next page >
© 2025
ADVI
  • image description
  • image description
INNOVATE@advi.com 202.509.0760 1000 F St NW, Suite 650 Washington, DC 20004

Subscribe

to get the latest news and insights from ADVI Health